Euthyroid Sick Syndrome as a Prognostic Indicator of COVID-19 Pulmonary Involvement, Associated With Poorer Disease Prognosis and Increased Mortality
Authors:
- 22 February 2022
- journal article
- research article
- Published by Elsevier in Endocrine Practice
- Vol. 28 (5) , 494-501
Abstract
No abstract availableKeywords
Funding Information
- Uniwersytet Medyczny w Lodzi (503/5-165-01/503-51-001-19-00)
This publication has 34 references indexed in Scilit:
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisJournal of Infection, 2020
- Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19Neurology, 2020
- Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in ChinaChest, 2020
- Relationship between thyroid function and ICU mortality: a prospective observation studyCritical Care, 2012
- Beyond Low Plasma T3: Local Thyroid Hormone Metabolism during Inflammation and InfectionEndocrine Reviews, 2011
- Thyroid Hormone Therapy for Obesity and Nonthyroidal Illnesses: A Systematic ReviewThe Journal of Clinical Endocrinology & Metabolism, 2009
- Predictive value of thyroid hormones on the first day in adult respiratory distress syndrome patients admitted to ICU: comparison with SOFA and APACHE II scoresAnnals of Saudi Medicine, 2005
- Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot studyEuropean Journal of Endocrinology, 2004
- Reduced Activation and Increased Inactivation of Thyroid Hormone in Tissues of Critically Ill PatientsThe Journal of Clinical Endocrinology & Metabolism, 2003
- Respiratory Muscle Strength in HypothyroidismChest, 1992